Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Pak J Med Sci ; 35(2): 583-585, 2019.
Article in English | MEDLINE | ID: mdl-31086555

ABSTRACT

Permanent central vein catheter for hemodialysis is a choice for hemodialysis vascular access. Permanent dialysis catheters may be inserted through the jugular, subclavian and femoral veins. It may be inserted when the patient have short life expectancy or not suitable for fistula operation. There may be so many complications for example malposition, hemorrhage and pneumothorax while inserting central venous catheter. Here we present a 44 year old female hemodialysis patient with a malpositioned permanent hemodialysis catheter, catheter tip was found in hepatic vein after three months of insertion.

2.
Int Urol Nephrol ; 47(8): 1397-401, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26135198

ABSTRACT

OBJECTIVE: Aging population has been increasing worldwide. So the number of elderly patients presenting with kidney disease has also been increasing. In this retrospective study, we assessed biopsy results of elderly patients and their clinical presentations. MATERIALS AND METHODS: Native renal biopsy results of 98 elderly patients (≥65 years) were analyzed. These 98 patients consisted of 56 males (57.1 %) and 42 females (42.9 %) with a mean age of 70.59 ± 5.31 years (65-88 years). RESULTS: The clinical presentations of our elderly patients were nephritic syndrome (n = 45), acute kidney injury (n = 35), nephrotic syndrome (n = 33), chronic kidney disease (n = 32) and combined nephritic and nephrotic syndrome (n = 14). In patients with nephritic syndrome, the most common diagnosis was crescentic GN (17.8 % type 3 and 13.3 % types 1 and 2). Crescentic GN was also the most frequent among patients with acute kidney injury (37.1 %), while membranous nephropathy was the major histopathological diagnosis in chronic kidney disease patients. In nephrotic syndrome, the most common histopathological diagnosis was AA amyloidosis. None of the patients had a major life-threatening complication. CONCLUSION: Biopsies in the elderly are as safe as in the general population. Renal biopsy should be performed to provide an accurate diagnosis and initiate specific treatment in elderly patients.


Subject(s)
Biopsy/methods , Kidney/pathology , Renal Insufficiency, Chronic/diagnosis , Aged , Aged, 80 and over , Female , Humans , Male , Reproducibility of Results , Retrospective Studies
3.
Kidney Blood Press Res ; 39(6): 648-57, 2014.
Article in English | MEDLINE | ID: mdl-25571878

ABSTRACT

BACKGROUND/AIMS: Continuous ambulatory peritoneal dialysis (CAPD) induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT) receptor antagonists have been found to be effective to prevent fibrosis in some nonperitoneal tissues. The aim of this study is to investigate the possible beneficial effect of montelukast, a LT receptor antagonist, on peritoneal membrane exposed to hypertonic peritoneal dialysis in uremic rats. METHODS: Of the 48 male, 5/6 nephrectomized Wistar rats 29 remained alive and were included in the study. These studied rats were divided into 3 groups: Group I (n=7) was the control group, Group II (n=8) was treated with 20 ml hypertonic PDF intraperitoneally daily and Group III was treated with montelukast and similar PDF treatment protocol. The morphological and functional changes in the peritoneal membrane as well as cytokine expression were compared between groups. RESULTS: Submesothelial thickness and the severity of the degree of hyaline vasculapathy were more prominent in group III when compared to group I. There were no significant differences between group II and other groups in terms of submesothelial thickness and the severity of the degree of hyaline vasculapathy. Increased expressions of TGF-ß and VEGF in parietal peritoneal membrane were found in group II and group III when compared to group I. The amount of TGF-ß and VEGF expression were similar in group II and group III. CONCLUSION: This study suggests that montelukast treatment does not prevent the peritoneal membrane from deleterious effects of hyperosmolar PDF in the uremic environment.


Subject(s)
Acetates/therapeutic use , Leukotriene Antagonists/therapeutic use , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneum/pathology , Quinolines/therapeutic use , Animals , Cyclopropanes , Cytokines/biosynthesis , Fibrosis/pathology , Fibrosis/prevention & control , Kidney Failure, Chronic/pathology , Male , Membranes/metabolism , Membranes/pathology , Peritoneum/metabolism , Rats , Rats, Wistar , Sulfides , Transforming Growth Factor beta/biosynthesis , Vascular Endothelial Growth Factor A/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...